Comprehensive review: antitumor necrosis factor agents in inflammatory bowel disease and factors implicated in treatment response.

导出 OA

翻译打印收藏纠错

第一作者： Gary R,Lichtenstein

第一单位： Center for Inflammatory Bowel Diseases, Perelman School of Medicine of the University of Pennsylvania, Department of Medicine, Gastroenterology Division, Hospital of the University of Pennsylvania, 9th Floor Penn Tower, One Convention Center, Philadelphia, PA 19104, USA.

作者： Gary R,Lichtenstein ^[1]

作者单位： Center for Inflammatory Bowel Diseases, Perelman School of Medicine of the University of Pennsylvania, Department of Medicine, Gastroenterology Division, Hospital of the University of Pennsylvania, 9th Floor Penn Tower, One Convention Center, Philadelphia, PA 19104, USA. ^[1]

关键词 Crohn’s disease adalimumab antitumor necrosis factor α certolizumab enzyme-linked immunosorbent assay immunogenicity inflammatory bowel disease infliximab ulcerative colitis

DOI 10.1177/1756283X13479826

PMID 23814608

发布时间 2024-04-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交